Exploration of neoadjuvant chemotherapy and post-tumor microenvironment for advanced gastric cancer (GC) or gastroesophageal junction cancer (EGJ)

被引：0
|
作者：
Gou, Miaomiao
Gao, Yunhe
Qiao, Zhi
Wang, Zhi-Kuan
Liu, Yi
Dai, Guanghai
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[3] Peoples Liberat Army Gen Hosp, Senior Dept Oncol, Med Ctr 5, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16099
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Tumor conferences show an association with neoadjuvant chemotherapy for gastric cancer
    Schulz, Stefanie
    Mussel, Caecilie
    Justenhoven, Christina
    GESUNDHEITSWESEN, 2025, 87 (01) : 11 - 13
  • [42] A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma
    Shi, Jin-Ming
    Li, Ning
    Jiang, Li-Ming
    Yang, Lin
    Wang, Shu-Lian
    Song, Yong-Wen
    Liu, Yue-Ping
    Fang, Hui
    Lu, Ning-Ning
    Qi, Shu-Nan
    Chen, Bo
    Li, Ye-Xiong
    Zhao, Dong-Bing
    Tang, Yuan
    Jin, Jing
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [43] Histopathological response to neoadjuvant chemotherapy is predictive for prognosis in locally advanced gastroesophageal cancer
    Spoerl, S.
    Al-Batran, S-E.
    Feith, M.
    Lordick, F.
    Thuss-Patience, P.
    Pauligk, C.
    Haller, B.
    Novotny, A.
    Lorenzen, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [44] Neoadjuvant Chemoradiotherapy Versus Surgery in Gastric and Gastroesophageal Junction Cancer: A Single Institutional Review
    Baltrusaitis, D.
    Cheng, H.
    Rajeev, R.
    Gamblin, T.
    Turaga, K.
    Johnston, F.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S172 - S173
  • [45] Early-stage gastric and gastroesophageal junction cancer: Is there a survival benefit to neoadjuvant therapy?
    Waller, Giacomo C.
    Patel, Dhruv J.
    Baker, Marshall S.
    SURGERY, 2022, 172 (06) : 1753 - 1758
  • [46] Evolving Standards of Care for Neoadjuvant and Adjuvant Therapy in Esophageal, Gastroesophageal Junction, and Gastric Cancer
    Chapin, William J.
    Massa, Ryan C.
    Eads, Jennifer R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 784 - 793
  • [47] Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer
    Ahmad, M. Usman
    Javadi, Christopher
    Poultsides, George A.
    CANCERS, 2022, 14 (07)
  • [48] Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer
    Zhang, Ning
    Li, Chunyu
    Zhao, Zehua
    Jiang, Biying
    Wang, Wentao
    Sun, Fujing
    Zhang, Yong
    Zhu, Yanmei
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [49] PREOPERATIVE TREATMENT WITH RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED GASTROESOPHAGEAL JUNCTION (GEJ) CANCER AND UNRESECTABLE LOCALLY ADVANCED GASTRIC CANCER
    Irena, Oblak
    Franc, Anderluh
    Vaneja, Velenik
    Jasna, But-Hadzic
    Ajra, Secerov-Ermenc
    Ana, Jeromen
    Ivica, Ratosa
    ANNALS OF ONCOLOGY, 2014, 25 : 45 - 45
  • [50] The potential drug cost impact of nivolumab (N) in patients with advanced/metastatic gastric cancer (GC) or gastroesophageal junction cancer (GEJC) in Canada.
    Virik, Kiran
    Wilson, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345